In addition to our previous review of the crucial role of asprosin, here we showed that oxytocin could ameliorate obesity-induced diabetes and decrease FBN1 gene expression centrally to block appetite. The gene discussed is FBN1; the disease is obesity due to melanocortin 4 receptor deficiency.